Literature DB >> 10423310

Bronchoalveolar lavage fluid cellularity and soluble intercellular adhesion molecule-1 in children with colds.

J Grigg1, J Riedler, C F Robertson.   

Abstract

Viral colds are an important cause of respiratory symptoms in normal children. Studies in adults suggest that inflammation in the lower respiratory tract is associated with viral colds, but there are no data regarding inflammation and viral infection in the lower airway of normal children with colds. We, therefore, studied the lower airway of two groups of children: Group I, those with active coryzal symptoms and a respiratory virus isolated from bronchoalveolar lavage fluid (BALF); and Group II: asymptomatic children who had had a clinical cold within the previous 2 weeks and no respiratory virus in BALF. Both groups were compared to age- and weight-matched normal noninfected controls, who had had no coryzal symptoms for at least 8 weeks. Viruses isolated from BALF of Group I (n = 7) were: respiratory syncytial virus (n = 2), rhinovirus (n = 3), parainfluenza I (n = 1), and echovirus 11 (n = 1). Compared to normal controls, Group I had an increased BALF lymphocyte and neutrophil differential count (P < 0.05), a concomitant depressed alveolar macrophage differential count (P < 0.05), and increased BALF concentrations of soluble intercellular adhesion molecule-1 (sICAM-1) (P < 0.05, n = 6), total protein (P < 0.05, n = 6) and albumin (P < 0.05, n = 7). Similar changes were seen in Group II (n = 22), with an increased BALF neutrophil (P < 0.05) and lymphocyte (P < 0.01) differential count, and increased concentrations of sICAM-1 (P < 0.01, n = 15), total protein (P < 0.0001, n = 9) and albumin (P = 0.05, n = 17). Our results suggest that inflammation and viral infection in the lower airway are present during active colds, and that inflammation is also present during the convalescent period. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423310     DOI: 10.1002/(sici)1099-0496(199908)28:2<109::aid-ppul6>3.0.co;2-5

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  6 in total

1.  Systemic neutrophil activation in acute preschool viral wheeze.

Authors:  A Oommen; R Patel; M Browning; J Grigg
Journal:  Arch Dis Child       Date:  2003-06       Impact factor: 3.791

2.  Overexpression of sICAM-1 in the alveolar epithelial space results in an exaggerated inflammatory response and early death in Gram negative pneumonia.

Authors:  Michael P Mendez; Yeni K Monroy; Ming Du; Angela M Preston; Leslie Tolle; Yujing Lin; Kelli L VanDussen; Linda C Samuelson; Theodore J Standiford; Jeffery L Curtis; James M Beck; Paul J Christensen; Robert Paine
Journal:  Respir Res       Date:  2011-01-19

3.  Cough and reflux esophagitis in children: their co-existence and airway cellularity.

Authors:  Anne B Chang; Nancy C Cox; Joan Faoagali; Geoffrey J Cleghorn; Christopher Beem; Looi C Ee; Geoffrey D Withers; Mark K Patrick; Peter J Lewindon
Journal:  BMC Pediatr       Date:  2006-02-27       Impact factor: 2.125

4.  Respiratory virus detection in nasopharyngeal aspirate versus bronchoalveolar lavage is dependent on virus type in children with chronic respiratory symptoms.

Authors:  Danielle F Wurzel; Julie M Marchant; Julia E Clark; Ian M Mackay; Claire Y T Wang; Theo P Sloots; John W Upham; Stephanie T Yerkovich; I Brent Masters; Peter J Baker; Sophie Anderson-James; Anne B Chang
Journal:  J Clin Virol       Date:  2013-09-23       Impact factor: 3.168

Review 5.  New treatment regimes for virus-induced exacerbations of asthma.

Authors:  Michael R Edwards; Tatiana Kebadze; Malcolm W Johnson; Sebastian L Johnston
Journal:  Pulm Pharmacol Ther       Date:  2005-11-10       Impact factor: 3.410

6.  RSV-induced bronchiolitis but not upper respiratory tract infection is accompanied by an increased nasal IL-18 response.

Authors:  Inesz J van Benten; Cornelis M van Drunen; Laurens P Koopman; Alex KleinJan; Barbara C van Middelkoop; Leon de Waal; Albert D M E Osterhaus; Herman J Neijens; Wytske J Fokkens
Journal:  J Med Virol       Date:  2003-10       Impact factor: 2.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.